More importantly, we found that PSA of B. fragilis inhibited the development of colitis-associated CRC in an azoxymethane (AOM)/DSS-induced animal model and that its beneficial effect against colon tumorigenesis was mainly determined by TLR2 signaling. The gene discussed is TLR2; the disease is colorectal carcinoma.